Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2575 of 3546 entries
View as:

A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00682279 Org: User:
Start: 09/30/08 End: 03/31/11 Due: 03/31/12

Comparing Two Respiratory Drugs When Used In Combination And Separately From A Novel Inhaler Device In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00538057 Org: User:
Start: 10/02/07 End: 12/01/07 Due: 12/01/08

To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00366366 Org: User:
Start: 09/30/01 End: 09/30/02 Due: 09/30/03

Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01159912 Org: User:
Start: 06/30/10 End: 01/16/12 Due: 01/16/13

Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT02075515 Org: User:
Start: 08/13/14 End: 04/25/16 Due: 04/25/17

Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT01098474 Org: User:
Start: 07/07/10 End: 03/16/12 Due: 03/16/13

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 60 Years and Above

Phase: N/A Priority: Normal
NCT ID: NCT04841577 Org: User:
Start: 04/27/21 End: 02/08/22 Due: 02/08/23

Lapatinib in Combination With Vinorelbine

Phase: N/A Priority: Normal
NCT ID: NCT01128543 Org: User:
Start: 04/30/09 End: 03/31/12 Due: 03/31/13

A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00463697 Org: User:
Start: 04/02/07 End: 08/04/07 Due: 08/04/08

A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT06551181 Org: User:
Start: 08/05/24 End: 09/12/25 Due: 09/12/26

A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT01098487 Org: User:
Start: 05/31/10 End: 05/31/14 Due: 05/31/15

Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children

Phase: N/A Priority: Normal
NCT ID: NCT00307021 Org: User:
Start: 04/07/06 End: 08/22/07 Due: 08/22/08

Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women

Phase: N/A Priority: Normal
NCT ID: NCT00689741 Org: User:
Start: 01/31/01 End: 04/30/03 Due: 04/30/04

Epidemiologic Survey to Describe the Current Medical Practice of General Practitioners Treating Subjects With Type 2 Diabetes Mellitus in Latina

Phase: N/A Priority: Normal
NCT ID: NCT01387165 Org: User:
Start: 10/31/04 End: 10/31/05 Due: 10/31/06

A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS

Phase: N/A Priority: Normal
NCT ID: NCT00400608 Org: User:
Start: 10/31/06 End: 02/28/07 Due: 02/28/08

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

Phase: N/A Priority: Normal
NCT ID: NCT04950712 Org: User:
Start: 06/09/21 End: 03/14/24 Due: 03/14/25

A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT05496231 Org: User:
Start: 08/22/22 End: 02/25/24 Due: 02/25/25

Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population

Phase: N/A Priority: Normal
NCT ID: NCT00306995 Org: User:
Start: 05/11/05 End: 07/04/06 Due: 07/04/07

Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics

Phase: N/A Priority: Normal
NCT ID: NCT01563081 Org: User:
Start: 04/30/12 End: 08/31/12 Due: 08/31/13

Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00107718 Org: User:
Start: 11/15/04 End: 05/19/06 Due: 05/19/07

A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT01138007 Org: User:
Start: 06/17/10 End: 08/07/12 Due: 08/07/13

Effect of a Commercial Cosmetic Mouth Rinse on Plaque Re-growth

Phase: N/A Priority: Normal
NCT ID: NCT01122862 Org: User:
Start: 04/30/10 End: 05/31/10 Due: 05/31/11

An Efficacy and Safety Study of Theraflu Night Powder as Oral Solution for Cold and Flu

Phase: N/A Priority: Normal
NCT ID: NCT02730364 Org: User:
Start: 02/01/17 End: 04/01/17 Due: 04/01/18

Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02683746 Org: User:
Start: 03/16/16 End: 05/15/17 Due: 05/15/18

A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01545570 Org: User:
Start: 11/07/11 End: 12/23/12 Due: 12/23/13